CanSino Biologics, Inc. Class H
CanSino Biologics, Inc. Class H (6185) is a biotechnology company based in China that specializes in the development, manufacturing, and commercialization of vaccines and biological products. The company focuses primarily on innovative vaccine solutions for infectious diseases, including its lead product, the Ad5-nCoV vaccine for COVID-19, and other candidates targeting diseases such as tuberculosis and influenza. CanSino operates in both the public and private healthcare sectors, aiming to improve global health outcomes through its advanced biopharmaceutical technologies.